SWI/SNF Chromatin Remodeling Loss and Human Cancer

描述（由申请人提供）：肿瘤抑制基因的鉴定导致了对人类癌症发展机制的新见解。这些基因的正常功能通常在于控制基因表达，特别是在细胞周期控制和细胞分化领域。最近的几项研究表明，染色质重塑复合物的异常活性与人类癌症的发生有关。INI1/SNF5基因突变是SWI/SNF染色质重塑复合物的一个组成部分，发生在大多数恶性横纹肌样肿瘤中。SWI/SNF复合物作为一种全局转录激活因子，通过能量依赖机制改变核小体在DNA上的定位。其他人和我们也证明了人SWI2同源物BRG 1和BRM在人肿瘤细胞系和原发性肿瘤中的缺失和/或突变。这两种蛋白质表达的缺失消除了Rb介导的细胞周期停滞。然而，这两种蛋白质似乎都调节关键癌症进展基因的表达，包括E钙粘蛋白和CD 44。此外，虽然BRG 1v/-小鼠发生腺癌，但BRM-/-小鼠没有显示出肿瘤发病率增加。因此，其中一种或两种蛋白质的表达缺失导致人类癌症病因学的机制仍未得到解决。我们已经观察到BRG 1诱导的基因表达与人类肿瘤细胞，特别是非小细胞肺癌（NSCLC）中启动子甲基化缺失之间的关联。基于这些研究，我们假设SWI/SNF复合物活性的丧失通过BRG 1和/或BRM的失活通过DNA甲基化促进基因沉默而在人类肿瘤进展期间加剧基因组不稳定性。为了验证这一假设，我们需要更好地了解BRG 1和BRM蛋白表达的缺失如何改变肿瘤细胞的生物学特性和癌症相关基因的染色质结构。在本申请中，我们将在第一个具体目标中鉴定这些蛋白质的重叠和独立的生物学和生物化学功能。在第二个具体目标中，我们将使用人气管支气管细胞培养模型确定这些蛋白质的丢失如何促进肺肿瘤的发展。在最后一个具体的目标，我们将描述的影响，BRG 1和BRM损失的染色质结构和DNA甲基化状态的重要靶基因。这些基因在人类癌症发展中的作用的解剖将拓宽我们对其正常生物学和生化功能的理解，提供新的见解DNA甲基化的控制和对治疗和检测这种临床上重要的肿瘤的影响。

DESCRIPTION (provided by applicant): The identification of tumor suppressor genes has led to new insights into the mechanisms of human cancer development. The normal functions of these genes often lie in the control of gene expression, especially in the realm of cell cycle control and cellular differentiation. Several recent studies have implicated aberrant activity of chromatin remodeling complexes in the development of human cancer. Mutations in the INI1/SNF5 gene, a component of the SWI/SNF chromatin remodeling complex, occur in the majority of malignant rhabdoid tumors. The SWI/SNF complex acts as a global transcriptional activator that alters nucleosome positioning on DNA via an energy-dependent mechanism. Others and we have also demonstrated the loss and/or mutations of both human SWI2 homologs, BRG1 and BRM, in human tumor cell lines and primary tumors. Loss of expression of both proteins abrogates Rb-mediated cell cycle arrest. However either protein appears to regulate the expression of key cancer progression genes including Ecadherin and CD44. Furthermore, while BRG1v/- mice develop adenocarcinomas, BRM-/- mice do not show an increased tumor incidence. Therefore, the mechanism by which loss of expression of either or both proteins contributes to the etiology of human cancers remains unresolved. We have observed an association between BRG1-induced gene expression and loss of promoter methylation in human tumor cells, especially Non-Small Cell Lung Carcinomas (NSCLC). Based on these studies, we hypothesize that loss of SWI/SNF complex activity through inactivation of BRG1 and/or BRM fuels genomic instability during human tumor progression by facilitating gene silencing through DNA methylation. To test this hypothesis, we require a better understanding how loss of expression of BRG1 and BRM proteins alters the biological properties of tumor cells and the chromatin structure of cancer related genes. In this application, we will identify overlapping and independent biological and biochemical functions of these proteins in the first specific aim. In the second specific aim, we will determine how the loss of these proteins contributes to lung tumor development using a human tracheobronchial cell culture model. In the last specific aim, we will characterize the effects of BRG1 and BRM loss on the chromatin structure and DNA methylation status of important target genes. The dissection of the role of these genes in human cancer development will broaden our understanding of their normal biological and biochemical functions, provide new insights into the control of DNA methylation and impact upon treatment and detection of this clinically important tumor.